https://www.has-sante.fr/jcms/p_3359432/fr/ayvakyt-avapritinib-mastocytose-systemique-agressive-asm https://www.has-sante.fr/jcms/p_3359458/fr/decision-n2022-0278/dc/sem-du-21-juillet-2022-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-ayvakyt 2022 false false false France adult Systemic Mastocytosis with an Associated Myeloid Neoplasm protein kinase inhibitors avapritinib leukemia, mast-cell treatment outcome insurance, health, reimbursement guidelines for drug use continuity of patient care administration, oral evaluation of the transparency committee avapritinib aggressive systemic mastocytosis mastocytosis, systemic
--- http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=98850 https://www.orpha.net/data/patho/Pro/fr/Urgences_Mastocytose-frPro13309.pdf 2013 France French mastocytosis, systemic emergency treatment practice guideline mastocytosis, systemic aggressive systemic mastocytosis
Currated CISMeF NLP mapping